# Transcode Therapeutics, Inc.: Form DEF 14A, filed Jun 2, 2026

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: DEF 14A
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 2, 2026, 20:05 ET
- Period: 2026-07-02
- Accession: 0001104659-26-069458
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926069458/tm2613174-4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465926069458/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465926069458/tm2613174-4_def14a.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-069458. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.